Trastuzumab-DM1 is highly effective in preclinical models of HER2-positive gastric cancer

Title
Trastuzumab-DM1 is highly effective in preclinical models of HER2-positive gastric cancer
Authors
Keywords
-
Journal
CANCER LETTERS
Volume 306, Issue 2, Pages 171-179
Publisher
Elsevier BV
Online
2011-05-03
DOI
10.1016/j.canlet.2011.03.002

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started